Literature DB >> 33124087

An examination of two dichotomies: Women with lung cancer and living with lung cancer as a chronic disease.

Tiziana Vavalà1, Maureen Rigney2, Maria Lucia Reale3, Silvia Novello3, Jennifer C King2.   

Abstract

Lung cancer remains the leading cause of cancer death globally, yet with many recent advances in the diagnosis and treatment of lung cancer, the face of the disease is shifting. Historically, lung cancer is often thought of as a predominantly male disease with more than twice as many men as women being diagnosed worldwide-mostly due to the influence of smoking as the leading risk factor. However, lung cancer is also the second leading cause of cancer death in women and there is a growing population of young women who have never smoked and are being diagnosed. The past decade has seen groundbreaking innovations in both the early detection and treatment of lung cancer. In this new era, survival rates are beginning to increase and many of those diagnosed are finding themselves in a new situation-living long term with a deadly cancer. Here, we review pertinent aspects of women and lung cancer as well as the concept of living with lung cancer as a chronic disease to give a new perspective on the changing face of lung cancer treatment and care.
© 2020 Asian Pacific Society of Respirology.

Entities:  

Keywords:  chronic disease; gender differences; lung cancer; survivorship

Mesh:

Substances:

Year:  2020        PMID: 33124087     DOI: 10.1111/resp.13965

Source DB:  PubMed          Journal:  Respirology        ISSN: 1323-7799            Impact factor:   6.424


  2 in total

1.  Tobacco Taxes as the Unsung Hero: Impact of a Tax Increase on Advancing Sustainable Development in Colombia.

Authors:  Norman Maldonado; Blanca Llorente; Luz Myriam Reynales-Shigematsu; Belen Saenz-de-Miera; Prabhat Jha; Geordan Shannon
Journal:  Int J Public Health       Date:  2022-03-30       Impact factor: 3.380

2.  MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1α axis.

Authors:  Shan Hu; Peng Cao; Kangle Kong; Peng Han; Yu Deng; Fan Li; Bo Zhao
Journal:  J Transl Med       Date:  2021-05-27       Impact factor: 5.531

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.